BANK OF AMERICA CORP /DE/
BankPosition in ORMP — Oramed Pharmaceuticals Inc.
CIK 70858
CHARLOTTE, NC
Position in ORMP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$724,837
+$227,921 QoQ
Shares Held
150,694
+3.1% QoQ
Ownership
0.362%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 84 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in ORMP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. ORMP ranks #229 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ORMP
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $724,837 | 150,694 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $496,916 | 146,152 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $405,392 | 142,243 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $395,120 | 149,667 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $322,663 | 143,406 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $350,306 | 163,695 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $405,720 | 167,653 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $420,147 | 172,192 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $445,228 | 173,241 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $838,191 | 287,052 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $626,940 | 271,403 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $53,601 | 20,537 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $114,240 | 31,911 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $124,882 | 57,286 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $226,848 | 18,857 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $162,498 | 25,077 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $181,993 | 39,737 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $610,784 | 70,611 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,192,808 | 83,530 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $501,428 | 22,813 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $262,300 | 19,604 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $178,499 | 17,569 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $57,328 | 13,521 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $1,827 | 700 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,471 | 700 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,258 | 743 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||